Australian company Neuren Pharmaceuticals (ASX:NEU) is set to receive a US$40 million milestone payment following the US launch of its treatment for Rett syndrome. …
Major milestone for emerging Australian pharmaceutical company
April 19, 2023 Latest NewsBioPharmaAustralian Biotech
Latest Video
New Stories
-
An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'
June 3, 2026 - - Latest News -
Patient voices take centre stage at the 2026 Patient's Choice Awards
June 3, 2026 - - Latest News -
Officials confirm shift in Budget management of underspends
June 3, 2026 - - Latest News -
Invitation confusion clouds Delphi studies and captures medical device sector
June 3, 2026 - - Latest News -
Omico opens a new chapter in precision oncology research
June 1, 2026 - - Latest News -
Ex-MA executive named the first CEO of Medicinal Cannabis Council Australia
June 1, 2026 - - Latest News -
Oral RAS inhibitor doubles median survival and cuts death risk in metastatic pancreatic cancer
June 1, 2026 - - Latest News